![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](cv2011contents.gif)
Acta Cryst. (2006). E62, m841-m842 [ doi:10.1107/S1600536806009883 ]
Abstract: In the title compound, [Cu(C18H12Br2N3O)(C10H8N2)]BF4, the Cu atom is pentacoordinated by three atoms, viz. N, N and O of the tridentate 2-[2-(1H-1,3-benzimidazol-2-yl)ethyliminomethyl]-2,4-dibromophenolate ligand and two N atoms of the 1,10-phenanthroline ligand. The Cu coordination geometry is highly distorted trigonal bipyramidal, with Cu-O and Cu-N bond lengths of 1.916 (3) and 1.954 (4)-2.212 (4) Å, respectively. The axial positions are occupied by two N atoms which form an N-Cu-N angle of 170.29 (16)°.
Online 22 March 2006
Copyright © International Union of Crystallography
IUCr Webmaster